Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot P22557 (HEM0_HUMAN)

Last modified September 2, 2008. Version 96. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (7) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    5-aminolevulinate synthase, erythroid-specific, mitochondrial
    EC=2.3.1.37
Alternative name(s):
    5-aminolevulinic acid synthase
    Delta-aminolevulinate synthase
    Delta-ALA synthetase
      Short name=ALAS-E
Gene names
Name: ALAS2
Synonyms: ALASE, ASB
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length587 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Catalytic activity

Succinyl-CoA + glycine = 5-aminolevulinate + CoA + CO(2).

Cofactor

Pyridoxal phosphate.

Pathway

Porphyrin metabolism; protoporphyrin-IX biosynthesis; 5-aminolevulinate from glycine: step 1/1.

Subunit structure

Homodimer.

Subcellular location

Mitochondrion matrix.

Tissue specificity

Erythroid specific.

Involvement in disease

Defects in ALAS2 are a cause of X-linked sideroblastic anemia (XLSA) [MIM:301300]. Sideroblastic anemia is characterized by anemia of varying severity, hypochromic peripheral erythrocytes, progressive accumulation of iron, and the presence of ringed sideroblasts in the bone marrow.

Miscellaneous

There are two delta-ALA synthetase in vertebrates: an erythroid- specific form and one (housekeeping) which is expressed in all tissues.

Sequence similarities

Belongs to the class-II pyridoxal-phosphate-dependent aminotransferase family.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical view

Molecule processing

Transit peptide1 – ?4949Mitochondrion
Chain?50 – 5875385-aminolevulinate synthase, erythroid-specific, mitochondrial

Sites

Binding site3911Pyridoxal phosphate (covalent) Probable

Natural variations

Natural variant1591D → Y in XLSA.
Natural variant1991Y → H in XLSA.
Natural variant2041R → Q in XLSA; 15% to 35% activity of wild-type.
Natural variant3881T → S in XLSA.
Natural variant4111R → C in XLSA; 12% to 25% activity of wild-type.
Natural variant4481R → Q in XLSA.
Natural variant4521R → C in XLSA.
Natural variant4761I → N in XLSA.
Natural variant5601R → H in XLSA.

Experimental info

Sequence conflict1821S → F in CAA39795. Ref.1

Sequences

Sequence LengthMass (Da)Tools
P22557-1 [UniParc].

Last modified January 23, 2002. Version 2.
Checksum: FD821BE245C440B5

FASTA58764,633
        10         20         30         40         50         60 
MVTAAMLLQC CPVLARGPTS LLGKVVKTHQ FLFGIGRCPI LATQGPNCSQ IHLKATKAGG 

        70         80         90        100        110        120 
DSPSWAKGHC PFMLSELQDG KSKIVQKAAP EVQEDVKAFK TDLPSSLVSV SLRKPFSGPQ 

       130        140        150        160        170        180 
EQEQISGKVT HLIQNNMPGN YVFSYDQFFR DKIMEKKQDH TYRVFKTVNR WADAYPFAQH 

       190        200        210        220        230        240 
FSEASVASKD VSVWCSNDYL GMSRHPQVLQ ATQETLQRHG AGAGGTRNIS GTSKFHVELE 

       250        260        270        280        290        300 
QELAELHQKD SALLFSSCFV ANDSTLFTLA KILPGCEIYS DAGNHASMIQ GIRNSGAAKF 

       310        320        330        340        350        360 
VFRHNDPDHL KKLLEKSNPK IPKIVAFETV HSMDGAICPL EELCDVSHQY GALTFVDEVH 

       370        380        390        400        410        420 
AVGLYGSRGA GIGERDGIMH KIDIISGTLG KAFGCVGGYI ASTRDLVDMV RSYAAGFIFT 

       430        440        450        460        470        480 
TSLPPMVLSG ALESVRLLKG EEGQALRRAH QRNVKHMRQL LMDRGLPVIP CPSHIIPIRV 

       490        500        510        520        530        540 
GNAALNSKLC DLLLSKHGIY VQAINYPTVP RGEELLRLAP SPHHSPQMME DFVEKLLLAW 

       550        560        570        580 
TAVGLPLQDV SVAACNFCRR PVHFELMSEW ERSYFGNMGP QYVTTYA 

« Hide

References

« Hide 'large scale' references
[1]"Two different genes encode delta-aminolevulinate synthase in humans: nucleotide sequences of cDNAs for the housekeeping and erythroid genes."
Bishop D.F.
Nucleic Acids Res. 18:7187-7188(1990) [PubMed: 2263504] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Liver.
[2]"Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA."
Cox T.C., Bawden M.J., Martin A., May B.K.
EMBO J. 10:1891-1902(1991) [PubMed: 2050125] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Liver.
[3]"Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene."
Surinya K.H., Cox T.C., May B.K.
J. Biol. Chem. 273:16798-16809(1998) [PubMed: 9642238] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[4]"The DNA sequence of the human X chromosome."
Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C. expand/collapse author list , Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A., Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S., Rogers J., Bentley D.R.
Nature 434:325-337(2005) [PubMed: 15772651] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[5]"X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase."
Cox T.C., Bottomley S.S., Wiley J.S., Bawden M.J., Matthews C.S., May B.K.
N. Engl. J. Med. 330:675-679(1994) [PubMed: 8107717] [Abstract]
Cited for: VARIANT XLSA SER-388.
[6]"Enzymatic defect in 'X-linked' sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency."
Cotter P.D., Baumann M., Bishop D.F.
Proc. Natl. Acad. Sci. U.S.A. 89:4028-4032(1992) [PubMed: 1570328] [Abstract]
Cited for: VARIANT XLSA ASN-476.
[7]"R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity."
Furuyama K., Uno R., Urabe A., Hayashi N., Fujita H., Kondo M., Sassa S., Yamamoto M.
Br. J. Haematol. 103:839-841(1998) [PubMed: 9858242] [Abstract]
Cited for: VARIANT XLSA CYS-411.
[8]"A novel mutation of the erythroid-specific gamma-aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia."
Harigae H., Furuyama K., Kudo K., Hayashi N., Yamamoto M., Sassa S., Sasaki T.
Am. J. Hematol. 62:112-114(1999) [PubMed: 10577279] [Abstract]
Cited for: VARIANT XLSA GLN-204.
[9]"Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis."
Cotter P.D., May A., Li L., Al-Sabah A.I., Fitzsimons E.J., Cazzola M., Bishop D.F.
Blood 93:1757-1769(1999) [PubMed: 10029606] [Abstract]
Cited for: VARIANTS XLSA HIS-199; CYS-411; GLN-448 AND CYS-452.
[10]"Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation."
Cazzola M., May A., Bergamaschi G., Cerani P., Ferrillo S., Bishop D.F.
Blood 100:4236-4238(2002) [PubMed: 12393718] [Abstract]
Cited for: VARIANT XLSA HIS-560.
[11]"A novel mutation in exon 5 of the ALAS2 gene results in X-linked sideroblastic anemia."
Hurford M.T., Marshall-Taylor C., Vicki S.L., Zhou J.Z., Silverman L.M., Rezuke W.N., Altman A., Tsongalis G.J.
Clin. Chim. Acta 321:49-53(2002) [PubMed: 12031592] [Abstract]
Cited for: VARIANT XLSA TYR-159.
+Additional computationally mapped references.

Web resources

Cross-references

Sequence databases

X56352 mRNA. Translation: CAA39795.1. Different initiation.
X60364 mRNA. Translation: CAA42916.1.
AF068624 Genomic DNA. Translation: AAC39838.1.
Z83821 Genomic DNA. No translation available.
AL020991 Genomic DNA. Translation: CAA15886.1.
PIRSYHUAE. S16347.
RefSeqNP_000023.2.
UniGeneHs.522666

3D structure databases

HSSPHSSP built from PDB template 1H7D based on UniProtKB P08680.
SMRP22557. Positions 1-49.
ModBaseSearch...

Genome annotation databases

EnsemblENSG00000158578. Homo sapiens. [Contig view]
GeneID212.
KEGGhsa:212.

Organism-specific databases

HGNCHGNC:397. ALAS2.
HPAHPA001638.
MIM301300. gene+phenotype.
Orphanet1047. Sideroblastic anaemia.
75563. Sideroblastic anaemia, X-linked.
PharmGKBPA24689.
GenAtlasSearch...
GeneCardsSearch...

Phylogenomic databases

HOGENOMP22557.
HOVERGENP22557.

Enzyme and pathway databases

ReactomeREACT_9431. Porphyrin metabolism.

Gene expression databases

ArrayExpressP22557.
CleanExHS_ALAS2.
GermOnlineENSG00000158578. Homo sapiens.

Family and domain databases

InterProIPR010961. 4pyrrol_synth_NH2levulA_synth.
IPR015118. 5aminolev_synth_preseq.
IPR004839. Aminotrans_I/II.
IPR001917. Aminotrans_II_pyridoxalP_BS.
IPR015421. PyrdxlP-dep_Trfase_major_sub1.
[Graphical view]
Gene3DG3DSA:3.40.640.10. PyrdxlP-dep_Trfase_major_sub1. 1 hit.
PfamPF00155. Aminotran_1_2. 1 hit.
PF09029. Preseq_ALAS. 1 hit.
[Graphical view]
TIGRFAMsTIGR01821. 5aminolev_synth. 1 hit.
PROSITEPS00599. AA_TRANSFER_CLASS_2. 1 hit.
[Graphical view]
ProDomP22557.
[Graphical view] [Entries sharing at least one domain]
BLOCKSSearch...

Other Resources

DrugBankDB00145. Glycine.
SOURCESearch...
ProtoNetSearch...

Entry information

Entry nameHEM0_HUMAN
AccessionPrimary (citable) accession number: P22557
Secondary accession number(s): Q13735
Entry history
Integrated into UniProtKB/Swiss-Prot: August 1, 1991
Last sequence update: January 23, 2002
Last modified: September 2, 2008
This is version 96 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome X

Human chromosome X: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PATHWAY comments

Index of metabolic and biosynthesis pathways

UniProtKB secondary accession numbers

Index of UniProtKB secondary accession numbers

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents